Theseus Pharmaceuticals Statistics
Total Valuation
Ibotta has a market cap or net worth of $948.16 million. The enterprise value is $676.64 million.
Important Dates
The next confirmed earnings date is Wednesday, August 13, 2025, after market close.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ibotta has 28.45 million shares outstanding. The number of shares has decreased by -7.28% in one year.
| Current Share Class | 25.31M |
| Shares Outstanding | 28.45M |
| Shares Change (YoY) | -7.28% |
| Shares Change (QoQ) | -1.13% |
| Owned by Insiders (%) | 17.62% |
| Owned by Institutions (%) | 30.59% |
| Float | 10.21M |
Valuation Ratios
The trailing PE ratio is 16.38 and the forward PE ratio is 26.03. Ibotta's PEG ratio is 2.08.
| PE Ratio | 16.38 |
| Forward PE | 26.03 |
| PS Ratio | 2.66 |
| Forward PS | 2.34 |
| PB Ratio | 2.45 |
| P/TBV Ratio | 2.47 |
| P/FCF Ratio | 8.33 |
| P/OCF Ratio | 8.14 |
| PEG Ratio | 2.08 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 55.93, with an EV/FCF ratio of 5.95.
| EV / Earnings | 11.28 |
| EV / Sales | 1.83 |
| EV / EBITDA | 55.93 |
| EV / EBIT | 68.60 |
| EV / FCF | 5.95 |
Financial Position
The company has a current ratio of 2.69, with a Debt / Equity ratio of 0.06.
| Current Ratio | 2.69 |
| Quick Ratio | 2.63 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 1.73 |
| Debt / FCF | 0.22 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 26.94% and return on invested capital (ROIC) is 2.29%.
| Return on Equity (ROE) | 26.94% |
| Return on Assets (ROA) | 1.28% |
| Return on Invested Capital (ROIC) | 2.29% |
| Return on Capital Employed (ROCE) | 2.23% |
| Revenue Per Employee | $417,044 |
| Profits Per Employee | $67,720 |
| Employee Count | 886 |
| Asset Turnover | 0.77 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -47.42M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.54% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -43.54% |
| 50-Day Moving Average | 40.00 |
| 200-Day Moving Average | 55.03 |
| Relative Strength Index (RSI) | 32.08 |
| Average Volume (20 Days) | 321,400 |
Short Selling Information
The latest short interest is 2.10 million, so 7.38% of the outstanding shares have been sold short.
| Short Interest | 2.10M |
| Short Previous Month | 1.64M |
| Short % of Shares Out | 7.38% |
| Short % of Float | 20.57% |
| Short Ratio (days to cover) | 5.65 |
Income Statement
In the last 12 months, Ibotta had revenue of $369.50 million and earned $60.00 million in profits. Earnings per share was $2.03.
| Revenue | 369.50M |
| Gross Profit | 312.80M |
| Operating Income | 9.86M |
| Pretax Income | n/a |
| Net Income | 60.00M |
| EBITDA | 12.10M |
| EBIT | 9.86M |
| Earnings Per Share (EPS) | $2.03 |
Full Income StatementBalance Sheet
The company has $297.13 million in cash and $25.60 million in debt, giving a net cash position of $271.52 million or $9.54 per share.
| Cash & Cash Equivalents | 297.13M |
| Total Debt | 25.60M |
| Net Cash | 271.52M |
| Net Cash Per Share | $9.54 |
| Equity (Book Value) | 401.28M |
| Book Value Per Share | 13.62 |
| Working Capital | 331.48M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $116.41 million and capital expenditures -$2.61 million, giving a free cash flow of $113.80 million.
| Operating Cash Flow | 116.41M |
| Capital Expenditures | -2.61M |
| Free Cash Flow | 113.80M |
| FCF Per Share | $4.00 |
Full Cash Flow StatementMargins
Gross margin is 84.66%, with operating and profit margins of 2.67% and 16.24%.
| Gross Margin | 84.66% |
| Operating Margin | 2.67% |
| Pretax Margin | 3.40% |
| Profit Margin | 16.24% |
| EBITDA Margin | 3.27% |
| EBIT Margin | 2.67% |
| FCF Margin | 30.80% |
Dividends & Yields
Ibotta does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.28% |
| Shareholder Yield | 7.28% |
| Earnings Yield | 6.33% |
| FCF Yield | 12.00% |
Dividend DetailsAnalyst Forecast
The average price target for Ibotta is $74.60, which is 123.82% higher than the current price. The consensus rating is "Buy".
| Price Target | $74.60 |
| Price Target Difference | 123.82% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ibotta has an Altman Z-Score of 6.28 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.28 |
| Piotroski F-Score | 5 |
